Pharmafile Logo

News and Press Releases

Sphere Fluidics launches Cyto-Mine Chroma and announces Early Access Program

Researchers invited to gain early access to next-generation platform to optimize functional single-cell analysis workflows across expanded applications in life science R&D 27 January 2025 – Cambridge, UK – Sphere...

Category: BioManufacturing
Posted: January 28, 2025

Sphere Fluidics
info@spherefluidics.com
The Jonas Webb Building, Babraham Research Campus, Babraham, Cambridge CB22 3AT, United Kingdom

New US headquarters opened by mass photometry pioneers Refeyn

Refeyn staff join mass photometry inventor Prof Philipp Kukura in cutting ribbon to Refeyn’s new US customer interaction centre in Massachusetts’ Waltham Biotech Hub 6 June 2024 -- Oxford, UK...

Category: BioManufacturing, Drug Discovery, Pharmaceutical
Posted: June 6, 2024

Refeyn
Unit 9, Trade City, Sandy Ln W, Oxford OX4 6FF, United Kingdom

Sphere Fluidics appoints Dale Levitzke as Chief Executive Officer

Dale Levitzke joins as Dr Frank F Craig, current CEO and co-founder, announces his retirement after leading the company for 14 years 30 April 2024 -- Cambridge, UK -- Sphere...

Category: Biotechnology, Other
Posted: April 30, 2024

Sphere Fluidics
info@spherefluidics.com
The Jonas Webb Building, Babraham Research Campus, Babraham, Cambridge CB22 3AT, United Kingdom